Alphatec Spine Reports 1Q19 Revenue of $24.6MM, +15.3% vs. 1Q18

by Mike Evers on May 15, 2019

Alphatec Spine reports 1Q19 revenue of USD $24.6MM, +15.3% vs. 1Q18.

Continued to update legacy-heavy portfolio with three new releases: the IdentiTi ACDF, the IdentiTi PLIF system and AlphaGRAFT DBM Fiber
Received FDA clearance for SafeOP neuromonitoring system
New products contributed 22% of U.S. revenue for the...

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

	1Q19	1Q18	$ Chg	% Chg
Spine	$22.3	$19.3	$2.9	15.2%
Orthobiologics	$2.3	$2.0	$0.3	16.5%
Total	$24.6	$21.3	$3.3	15.3%

Geographic Region	1Q19	1Q18	$ Chg	% Chg
US	$23.0	$19.2	$3.8	19.6%
Ex-US	$1.6	$2.1	-$0.5	-23.8%
Total	$24.6	$21.3	$3.3	15.3%

1Q19	Amount	% of Sales
Sales	$24.6
Cost of Sales	-$8.0	32.5%
Selling and Admin	-$21.0	85.5%
R & D	-$3.5	14.1%
Other	-$5.1	20.6%
Net Earnings	-$13.0	-52.8%

	1Q19	1Q18	$ Chg	% Chg
Spine	$22.3	$19.3	$2.9	15.2%
Orthobiologics	$2.3	$2.0	$0.3	16.5%
Total	$24.6	$21.3	$3.3	15.3%

Geographic Region	1Q19	1Q18	$ Chg	% Chg
US	$23.0	$19.2	$3.8	19.6%
Ex-US	$1.6	$2.1	-$0.5	-23.8%
Total	$24.6	$21.3	$3.3	15.3%

Alphatec Spine Reports 1Q19 Revenue of $24.6MM, +15.3% vs. 1Q18

Medtronic Offsets VBP with Strength in U.S.

ZimVie Sees Substantial Opportunity in Enabling Technology

Bioventus Lowers 2022 Guidance, Pauses M&A

Chart of the Month: Knee and Hip Recovery Trends

Ortho Market Pressures Moderated in 3Q, Year-End Surge Unlikely

Get the ORTHOWORLD Newsletter!

Contact Us